Erratum: Well-defined aminooxy terminated N -(2-hydroxypropyl) methacrylamide macromers for site specific bioconjugation of glycoproteins (Bioconjugate Chemistry (2013) 24:6 (865?877) DOI: 10.1021/bc300472e);Well-defined aminooxy terminated N -(2-Hydroxypropyl) methacrylamide macromers for site specific bioconjugation of glycoproteins

Bioconjugate Chemistry

Volumn 24, Issue 6, 2013, Pages 865-877

  Dhal, Pradeep K ^a   Polomoscanik, Steven C ^a   Gianolio, Diego A ^a   Starremans, Patrick G ^a   Busch, Michelle ^a   Alving, Kim ^a   Chen, Bo ^a   Miller, Robert J ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; BIOCOMPATIBILITY; BIOMOLECULES; CHAINS; ELECTROPHORESIS; FLUORESCENCE MICROSCOPY; FREE RADICAL POLYMERIZATION; GEL PERMEATION CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT DISTRIBUTION; MONOMERS;

AMIDE BOND; AMINOOXY GROUPS; BIO-CONJUGATION; BIOCONJUGATES; CHAIN TRANSFER AGENTS; CONTROLLED MOLECULAR WEIGHT; MACROMERS; METHACRYLAMIDES; SITE-SPECIFIC; SYNTHESIS AND CHARACTERIZATIONS;

PROTEINS;

GLYCOPROTEIN; N (2 HYDROXYPROPYL)METHACRYLAMIDE; N HYDROXYSUCCINIMIDE; RHODAMINE B; SIALIC ACID; TRANSFERRIN;

ANIMAL CELL; ARTICLE; BIOCONJUGATION; CHEMICAL STRUCTURE; CONJUGATION; CRYSTALLIZATION; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR PROBE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OXIDATION; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOSPECIFICITY; SYNTHESIS;

EID: 84879384551     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc4002932     Document Type: Erratum

References (82)

1. Duncan, R. (2003) The dawning era of polymer therapeutics Nat. Rev. Drug Discovery 2 (5) 347-360
2. Dhal, P. K., Polomoscanik, S. C., Avila, L. Z., Holmes-Farley, S. R., and Miller, R. J. (2009) Functional polymers as therapeutic agents: concept to marketplace Adv. Drug Delivery Rev. 61 (13) 1121-1130
3. Liu, S., Maheshwari, R., and Kiick, K. L. (2008) Polymer-based therapeutics Macromolecules 42 (1) 3-13
4. Vicent, M. J., Diuedonne, L., Carbajo, L. J., and Pineda-Lucena, A. (2008) Polymer conjugates as therapeutics: future trends, challenges, and opportunities Expert Opin. Drug Delivery 5 (5) 593-614
5. Haag, R. and Kratz, F. (2006) Polymer therapeutics: concepts and applications Angew. Chem., Int. Ed. Engl. 45, 1198-1215
6. Almutairi, A., Guillaudeu, S. J., Berezin, M. Y., Achilefu, S., and Frechet, J. M. J. (2008) Biodegradable pH-sensing dendritic nanoprobes for near-infrared fluorescence lifetime and intensity imaging J. Am. Chem. Soc. 130 (2) 444-445
7. Teles, F. R. R. and Fonseca, L. P. (2008) Applications of polymers for biomolecule immobilization in electrochemical biosensors Mater. Sci. Eng. C: Mater. Biol. Appl. 28 (8) 1530-1543
8. Harris, J. M. and Chess, R. B. (2003) Effect of pegylation of pharmaceuticals Nat. Rev. Drug Discovery 2 (3) 214-221
9. Pascut, G. and Veronese, F. M. (2007) Polymer-drug conjugations: recent achievements and general strategies Prog. Polym. Sci. 32, 933-961
10. Alconcel, S. N. S., Baas, A. S., and Maynard, H. D. (2011) FDA-approved poly(ethylene glycol)-protein conjugated drugs Polym. Chem. 2, 1442-1448
11. Fishburn, C. S. (2008) The pharmacology of pegylation: balancing PD with PK to generate novel therapeutics J. Pharm. Sci. 97 (10) 4167-4183
12. Kang, J. S., DeLuca, P. P., and Lee, K. C. (2009) Emerging pegylated drugs Expert Opin. Emerging Drugs 14 (2) 363-380
13. Barz, M., Luxenhofer, R., Zentel, R., and Vicent, M. J. (2011) Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure-property relationships to better defined therapeutics Polym. Chem. 2 (9) 1900-1918
14. Megan, E., Fox, M. E., Szoka, F. C., and Frechet, J. M. J. (2009) Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture Acc. Chem. Res. 42 (8) 1141-1151
15. Adams, N. and Schubert, U. S. (2007) Poly(2-oxazolines) in biological and biomedical application contexts Adv. Drug Delivery Rev. 59 (15) 1504-1520
16. Kopecek, J. and Kopeckova, P. (2010) HPMA copolymers: Origins, early developments, present, and future Adv. Drug Delivery Rev. 62 (2) 122-149
17. Duncan, R. and Vicent, M. J. (2010) Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities Adv. Drug Delivery Rev. 62 (2) 272-282
18. Rihova, B. (2007) Biocompatibility and immunocompatibility of water-soluble polymers based on HPMA Composites, Part B: Engineering 38B (3) 386-397
19. Kopeček, J., Kopečková, P., Minko, T., and Lu, Z. (2000) HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action Eur. J. Pharm. Biopharm. 50 (1) 61-81
20. Nowotnik, D. P. (2011) AP5346 (ProLindac), a DACH platinum polymer conjugate in phase II trials against ovarian cancer Curr. Bioactive Comp. 7 (1) 21-26
21. Seymour, L. W. 2009, Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer Int. J. Oncol. 34 (6) 1629-1636
22. Pan, H., Sima, M., Kopečková, P., Wu, K., Gao, S., Liu, J., Wang, D., Miller, S. C., and Kopeček, J. (2008) Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates Mol. Pharmacol. 5 (4) 548-558
23. Wang, D., Kopečková, P., Minko, T., Nanayakkara, V., and Kopeček, J. (2000) Synthesis of starlike N-(2-hydroxypropyl) methacrylamide copolymers: Potential drug carriers Biomacromolecules 1 (3) 313-319
24. Johnson, R. N., Kopečková, P., and Kopeček, J. (2009) Synthesis and evaluation of multivalent branched HPMA copolymer-Fab' conjugates targeted to the B-Cell antigen CD2 Bioconjugate Chem. 20 (1) 129-137
25. Gasper, R. and Duncan, R. (2009) Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics Adv. Drug Delivery Rev. 61 (13) 1220-1231
26. Ouchi, M., Terashima, T., and Sawamoto, M. (2009) Transition metal-catalyzed Living radical polymerization: Toward perfection in catalysis and precision polymer synthesis Chem. Rev. 109 (11) 4963-5050
27. Moad, G., Rizzardo, E., and Thang, S. H. (2009) Living radical Polymerization by the RAFT process-A second update Aust. J. Chem. 62 (11) 1402-1472
28. Braunecker, W. A. and Matyjaszewski, K. (2008) Controlled/living radical polymerization: Features, developments, and perspectives Prog. Polym. Sci. 32 (1) 93-146
29. Ouchi, M., Terashima, T., and Sawamoto, M. (2008) Precision control of radical polymerization via transition metal catalysis: From dormant species to designed catalysts for precision functional polymers Acc. Chem. Res. 41 (9) 1120-1132
30. Bays, E., Tao, L., Chang, C.-W., and Maynard, H. D. (2009) Synthesis of semitelechelic maleimide poly(PEGA) for protein conjugation by RAFT polymerization Biomacromolecules 10 (7) 1777-1781
31. Droumaguet, B. L and Nicolas, J. (2010) Recent advances in the design of bioconjugates from controlled/living radical polymerization Polym. Chem. 1 (5) 563-598
32. Grover, G. N and Maynard, H. D. (2010) Protein-polymer conjugates: synthetic approaches by controlled radical polymerizations and interesting applications Curr. Opin. Chem. Biol. 14 (6) 818-827
33. Jones, M. W., Mantovani, G., C. A., Blindauer, C. A., Ryan, S. M., Wang, X., Brayden, D. J., and Haddleton, D. M. (2012) Direct peptide bioconjugation/PEGylation at tyrosine with linear and branched polymeric diazonium salts J. Am. Chem. Soc. 134 (17) 7406-7013
34. Godwin, A., Hartenstein, M., Muller, A. H. E., and Brocchini, S. (2001) Narrow molecular weight distribution precursors for polymer-drug conjugates Angew. Chem., Int. Ed. 40 (3) 594-597
35. Barz, M., Canal, F., Koynov, K., Zentel, R., and Vicent, M. J. (2010) Synthesis and in vitro evaluation of defined HPMA folate conjugates: influence of aggregation on folate receptor (FR) mediated cellular uptake Biomacromolecules 11 (9) 2274-22282
36. Yong, S. Y. and Putnam, D. (2007) Overcoming limiting side reactions associated with an NHS-activated precursor of polymethacrylamide-based polymers Bioconjugate Chem. 18 (3) 970-982
37. Scales, C. W., Vasilieva, Y. A., Convertine, A. J., Lowe, A. B., and McCormick, C. L. (2005) Direct, controlled synthesis of the nonimmunogenic, hydrophilic polymer, poly(N-(2-hydroxypropyl)-methacrylamide) via RAFT in aqueous media Biomacromolecules 6 (4) 1846-1850
38. York, A. W., Huang, F., and McCormick, C. L. (2010) Rational design of targeted cancer therapeutics through the multiconjugation of folate and cleavable siRNA to RAFT-synthesized (HPMA-s-APMA) copolymers Biomacromolecules 11 (2) 505-514
39. Pan, H., Yang, J., Kopeckova, P., and Kopecek, J. (2011) Backbone degradable multiblock N-(2-hydroxypropyl) methacrylamide copolymer conjugates via reversible addition-fragmentation chain transfer polymerization and thiol-ene coupling reaction Biomacromolecules 12 (1) 47-252
40. Lemieux, G. A. and Bertozzi, C. R. (1998) Chemoselective ligation reactions with proteins, oligosaccharides and cells Trends Biotechnol. 16 (12) 506-513
41. Peri, F. and Nicotra, F. (2004) Chemoselective ligation in glycochemistry Chem. Commun. 6, 627-627
42. Dirksen, A., Hackeng, T. M., and Dawson, P. E. (2006) Nucleophilic catalysis of oxime ligation Angew. Chem., Int. Ed. 45 (45) 7581-7584
43. Kalia, J. and Raines, R. T. (2008) Hydrolytic stability of hydrazones and oximes Angew. Chem., Int. Ed. 47 (39) 7523-7526
44. Jones, D. S., Branks, M. J., Campbell, M.-A., Cockerill, K. A., Hammaker, J. R., Kessler, C. A., Smith, E. M., Tao, A., Ton-Nu, H.-T., and Xu, T. (2003) Multivalent poly(ethylene glycol)-containing conjugates for in vivo antibody suppression Bioconjugate Chem. 14 (6) 1067-1076
45. Zhou, Q., Stefano, J. E., Harrahy, J., Finn, P., Avila, L., Kyazike, J., Wei, R., Van Patten, S. M., Gotschall, R., Zheng, X., Zhu, Y., Edmunds, T., and Pan, C. Q. (2011) Strategies for neoglycan conjugation to human acid α-glucosidase Bioconjugate Chem. 14 (6) 1067-1076
46. Henderson, G. E., Isett, K. D., and Gerngross, T. U. (2011) Site-specific modification of recombinant proteins: a novel platform for modifying glycoproteins expressed in E. coli Bioconjugate Chem. 22 (5) 903-912
47. Werlen, R. C., Lankinen, M., Offord, R. E., Schubiger, P. A., Smith, A., and Rose, K. (1996) Preparation of a trivalent antigen-binding construct using polyoxime chemistry: Improved biodistribution and potential for therapeutic application Cancer Res. 56 (4) 809-815
48. Zatsepin, T. S., Stetsenko, D. A., Gait, M. J., and Oretskaya, T. S. (2005) Use of carbonyl group addition-elimination reactions for synthesis of nucleic acid conjugates Bioconjugate Chem. 16 (3) 471-489
49. Maynard, H. D., Heredia, K. L., Li, R. C., Parra, D. P., and Vazquez-Dorbatt, V. (2007) Thermoresponsive biohybrid materials synthesized by ATRP J. Mater. Chem. 17 (38) 4015-4017
50. Vazquez-Dorbatt, V., Tolstyka, Z. P., and Maynard, H. D. (2009) Synthesis of aminooxy end-functionalized pNIPAAm by raft polymerization for protein and polysaccharide conjugation Macromolecules 42 (20) 7650-7656
51. Esser-Kahn, A. P. and Francis, M. B. (2008) Protein-cross-linked polymeric materials through site-selective bioconjugation Angew. Chem., Int. Ed. 47 (20) 3751-3754
52. Chytil, P., Etrych, T., Kriz, J., Subr, V., and Ulbrich, K. (2010) N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumor targeting. Synthesis by RAFT polymerization and physicochemical characterization Eur. J. Pharm. Sci. 41 (3-4) 473-482
53. Mitsukami, Y., Donovan, M. S., Lowe, A. B., and McCormick, C. L. (2001) Water-soluble polymers. 81. Direct synthesis of hydrophilic styrenic-based homopolymers and block copolymers in aqueous solution via RAFT Macromolecules 34 (7) 2248-2256
54. Kumar, S., Roy, S. G., and De, P. (2012) Cationic methacrylate polymers containing chiral amino acid moieties: controlled synthesis via RAFT polymerization Polym. Chem. 3 (5) 1239-1248
55. El- Faham, A. and Fernando Albericio, F. (2011) Peptide-coupling reagents. In Amino Acids, Peptides and Proteins in Organic Chemistry: Building Blocks, Catalysis and Coupling Chemistry (Hughes, A. B., Ed.) pp 407-444, Vol. 3, Wiley-VCH, Weinheim.
56. Yanjarappa, M. J., Gujraty, K. V., Joshi, A., Saraph, A., and Kane, R. S. (2006) Synthesis of copolymers containing an active ester of methacrylic acid by raft: controlled molecular weight scaffolds for biofunctionalization Biomacromolecules 7 (5) 1665-1670
57. Nicolas, J., Khoshdel, E., and Haddleton, D. M. (2007) Bioconjugation onto biological surfaces with fluorescently labeled polymers Chem. Commun. 17, 1722-1724
58. Hart-Smith, G. and Barner-Kowollik, C. (2010) Contemporary mass spectrometry and the analysis of synthetic polymers: trends, techniques and untapped potential Macromol. Chem. Phys. 211 (14) 1507-1529
59. Kim, J.-H., Park, K., Nam, H. Y., Lee, S., Kim, K., and Kwon, I. C. (2007) Polymers for bioimaging Prog. Polym. Sci. 32, 1031-1053
60. Lorenz, M. R., Holzapfel, V., Musyanovych, A., Nothelfer, K., Walther, P., Frank, H., Katharina Landfester, K., Schrezenmeier, H., and Mailander, V. (2006) Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells Biomaterials 27, 2820-2828
61. Saad, M., Ola B. Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., and Minko, T. (2008) Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging? J. Controlled Release 130, 107-114
62. Almutairi, A., Rossin, R., Shokeen, M., Hagooly, A., Ananth, A., Capoccia, B., Guillaudeu, S., Abendschein, D., Anderson, C. J., Welch, M. J., and Frechet, J. M. J. (2008) Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis Proc. Natl. Acad. Sci. U.S.A. 106 (3) 685-690
63. Patil, R. R., Yu, J., Banerjee, S. R., Ren, Y., Leong, D., Jiang, X., Pomper, M., Tsui, B., Kraitchman, D. L., and Mao, H.-Q. (2011) Probing in vivo trafficking of polymer /DNA micellar nanoparticles using SPECT /CT imaging Mol. Therapy 19 (9) 1626-1635
64. Weissleder, R., Tung, C.-H., Mahmood, U., and Bogdanov, A. (1999) In vivo imaging of tumors with protease activated near-infrared fluorescent probes Nat. Biotechnol. 17 (4) 375-378
65. Almutairi, A., Akers, W. J., Mikhail, Y., Berezin, M. Y., Achilefu, S., and Frechet, J. M. J. (2008) Monitoring the biodegradation of dendritic near-infrared nanoprobes by in vivo fluorescence imaging Mol. Pharmaceutics 5 (6) 1103-1110
66. Li, X. and Yang, D. (2006) Peptides of aminooxy acids as foldamers Chem. Commun. 31, 3367-3379
67. Meier, O. and Greber, U. F. (2004) Adenovirus endocytosis J. Gene Med. 6 (S1) S152-S163
68. Gump, J. M. and Dowdy, S. F. (2007) TAT transduction: the molecular mechanism and therapeutic prospects Trends Mol. Med. 13 (10) 443-448
69. Kochendoerfer, G. G. 2003, Design and chemical synthesis of a homogeneous polymer -modified erythropoiesis protein Science 299 (5608) 884-887
70. Liu, C. C. and Schultz, P. G. (2010) Adding new chemistries to the genetic code Annu. Rev. Biochem. 79, 413-444
71. Scheck, R. A., Dedeo, M. T., Iavarone, A. T., and Francis, M. B (2008) Optimization of a biomimetic transamination reaction J. Am. Chem. Soc. 130 (35) 11762-11770
72. Wu, P., Shui, W., Carlson, B. L., Hu, N., Rabuka, D., Lee, J., and Bertozzi, C. R. (2009) Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag Proc. Natl. Acad. Sci. U.S.A. 106 (9) 3000-3005
73. Beck, A., Cochet, O., and Wurch, T. (2010) GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins Expert Opin. Drug Discovery 5 (1) 95-111
74. Ho, R. and McConkey, B. J. (2011) Modulating glycosylation of recombinant monoclonal antibodies for therapeutic applications Curr. Top. Biotechnol. 6, 57-69
75. Zeng, Y., Ramya, T. N. C., Dirksen, A., Dawson, P. E., and Paulson, J. C. (2009) High-efficiency labeling of sialylated glycoproteins on living cells Nat. Methods 6 (3) 207-209
76. Zhang, H., Li, X. J., Martin, D. B., and Aebersold, R. (2009) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry Nat. Biotechnol. 21 (6) 660-666
77. Baker, E. N. (1994) Structure and reactivity of transferrins Adv. Inorg. Chem. 41, 389-463
78. Qian, Z. M., Li, H., Sun, H., and Ho, K. (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway Pharm. Rev. 54 (4) 561-587
79. Bellocq, N. C., Pun, S. H., Gregory S. Jensen, G. S., and Davis, M. E. (2003) Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery Bioconjugate Chem. 14 (6) 1122-1132
80. Sun, H., Li, H., and Sadler, P. J. (1999) Transferrin as a metal ion mediator Chem. Rev. 99 (9) 2817-2842
81. Pones, B., Mouhoubi, L., Adib, A., Godzina, P., Behr, J.-P., and Zuber, G. (2006) ω-Hydrazino linear polyethylenimine: A monoconjugation building block for nucleic acid delivery ChemBioChem 7 (2) 303-309
82. Dell, A. and Morris, H. R. (2001) Glycoprotein structure determination by mass spectrometry Science 291 (5512) 2351-2356